RE:RE:RE:RE:RE:RE:RE:RE:RE:earnings multipleWell they won't get it for 8X, so end this leaky sale sh*t. Pay 50% of the debt off over the next 4 years and let the stock tripple.
I also doubt any UK price change will happen. The UK exhibits one of the highest prices for branded products and the
lowest prices for generics in Europe. UK generics pricing levels have long been admired by many other European countries. If that is not enough, the public only pay 10 GBP a script (NHS pays the rest).
d_trump wrote: Yes as a strategic buy, 11x is reasonable. Private Equity however would not pay 11 times IMHO.